J&J Says It Will Spend $2B to Expand Biopharmaceutical Manufacturing in U.S.

Johnson & Johnson said it will increase its presence in North Carolina with a more than 160,000-square-foot dedicated manufacturing facility at FUJIFILM’s new biopharmaceutical manufacturing site in Holly Springs, North Carolina.

The company said the $2 billion commitment to FUJIFILM over the next 10 years will expand the its U.S. manufacturing capacity and create approximately 120 new jobs in North Carolina.

In the coming months, J&J also intends to share the plans for additional manufacturing facilities in the U.S. as well as the expansion of current U.S. sites.

In March, the Company announced it will invest $55 billion to support U.S. manufacturing, research and development, and technology investments over the next four years.

• Progress continues in the construction of the Wilson, North Carolina facility, which will employ more than 500 people when fully operational and create approximately 5,000 construction jobs during the site development.
• Other investments include extensive R&D infrastructure aimed at developing lifesaving and life-changing treatments in areas such as oncology, neuroscience, immunology, cardiovascular disease, and robotic surgery.